Preparation and characterization of nanofibers containing amorphous drug dispersions generated by electrostatic spinning

被引:277
作者
Verreck, G
Chun, I
Peeters, J
Rosenblatt, J
Brewster, ME
机构
[1] Johnson & Johnson Pharmaceut Res & Dev, B-2340 Beerse, Belgium
[2] Johnson & Johnson Corp Ctr Biomat & Adv Technol, Somerville, NJ USA
关键词
electrostatic spinning; amorphous solid dispersion; itraconazole; improved dissolution rate;
D O I
10.1023/A:1023450006281
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. We assessed the application of water-soluble polymer-based nanofibers prepared by electrostatic spinning as a means of altering the dissolution rate of the poorly water-soluble drug, itraconazole. Methods. Organic solvent-based solutions of itraconazole/HPMC mixtures were electrostatically spun at 16 and 24 kV. The formed nanofibers were collected as a non-woven fabric. The samples were analyzed by scanning electron microscopy, differential scanning calorimetry, and dissolution rate. Results. Scanning electron microscopy showed fiber diameters of 1-4 mum and 300-500 nm depending on the applied voltage. Differential scanning calorimetry measurements found that the melting endotherm for itraconazole was not present, suggesting the formation of an amorphous solid dispersion or solution. Dissolution studies assessed several presentations including direct addition of the non-woven fabrics to the dissolution vessels, folding weighed samples of the materials into hard gelatin capsules and placing folded material into a sinker. Controls included a physical mixture as well as solvent cast and melt extruded samples. Electrospun samples dissolved completely over time with the rate of dissolution depending on the formulation presentation and drug to polymer ratio. The physical mixture did not appreciably dissolve in these conditions. Conclusions. The application of electrostatic spinning to pharmaceutical applications resulted in dosage forms with useful and controllable dissolution properties.
引用
收藏
页码:810 / 817
页数:8
相关论文
共 31 条
[1]  
[Anonymous], [No title captured], Patent No. 0154667
[2]  
BAERT LEC, 1997, Patent No. 9744014
[3]  
BAERT LEC, 1997, Patent No. 9718839
[4]   Pharmacology of itraconazole [J].
De Beule, K ;
Van Gestel, J .
DRUGS, 2001, 61 (Suppl 1) :27-37
[5]   Controlled deposition of electrospun poly(ethylene oxide) fibers [J].
Deitzel, JM ;
Kleinmeyer, JD ;
Hirvonen, JK ;
Tan, NCB .
POLYMER, 2001, 42 (19) :8163-8170
[6]  
DOSHI J, 1995, J ELECTROSTAT, V35, P151, DOI 10.1016/0304-3886(95)00041-8
[7]  
ERKOBONI D, 2000, Patent No. 0056726
[8]  
Gilis PMV., 1997, US Patent, Patent No. [5633015, 5633015A]
[9]   IDEAL COPOLYMERS AND THE 2ND-ORDER TRANSITIONS OF SYNTHETIC RUBBERS .1. NON-CRYSTALLINE COPOLYMERS [J].
GORDON, M ;
TAYLOR, JS .
JOURNAL OF APPLIED CHEMISTRY, 1952, 2 (09) :493-500
[10]   ITRACONAZOLE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC USE IN SUPERFICIAL AND SYSTEMIC MYCOSES [J].
GRANT, SM ;
CLISSOLD, SP .
DRUGS, 1989, 37 (03) :310-344